Suchergebnisse - "Mou, Haiwei"

PubPharm (63)

1

Dietary suppression of MHC-II expression in intestinal stem cells enhances intestinal tumorigenesis

enthalten in: bioRxiv.org | 2023

von Beyaz, S. | Roper, J. | Bauer-Rowe, K. | +26

2

Patient-derived melanoma organoid models facilitate the assessment of immunotherapies

enthalten in: EBioMedicine | 2023

von Ou, L. | Liu, S. | Wang, H. | +20

3

CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer

enthalten in: The Journal of pathology | 2023

von Mou, H. | Eskiocak, O. | Özler, K. | +12

4

The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice

enthalten in: Reproduction (Cambridge, England) | 2023

von Cecchini, K. | Biasini, A. | Yu, T. | +10

5

A path to translation : How 3D patient tumor avatars enable next generation precision oncology

enthalten in: Cancer cell | 2022

von Bose, S. | Barroso, M. | Chheda, M. | +23

6

A-MYB/TCFL5 regulatory architecture ensures the production of pachytene piRNAs in placental mammals

enthalten in: RNA (New York, N.Y.) | 2022

von Yu, T. | Biasini, A. | Cecchini, K. | +8

7

CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer

enthalten in: bioRxiv.org | 2022

von Mou, H. | Yue, J. | Jin, Y. | +8

8

Tissue-specific Genome Editing in vivo by MicroRNA-repressible Anti-CRISPR Proteins

enthalten in: bioRxiv.org | 2021

von Lee, J. | Mou, H. | Ibraheim, R. | +3

9

Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis

enthalten in: Cell stem cell | 2021

von Beyaz, S. | Chung, C. | Mou, H. | +30

CommentIn: Nat Rev Immunol. 2021 Nov;21(11):692-693. - PMID 34535786

10

The testis-specific transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in placental mammals

enthalten in: bioRxiv.org | 2021

von Özata, D. | Yu, T. | Cecchini, K. | +8

1
2
3
4
5
6
7
Nächster »
[7]